Fig. 3: RETA treatment significantly alters gene expression in KPCY tumors which is restored with RETA-w/d.
From: Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression
Principal component analysis (PCA) plots of gene expression analysis using RNAseq data is shown.
